Novartis terminates agreement with Mesoblast (ASX:MSB)
Latest Company News - Finance News Network
English - December 14, 2021 03:15 - 1000 KBBusiness News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Woodside Petroleum (ASX:WPL) appoints new Chief Financial Officer
Next Episode: Polynovo (ASX:PNV) US sales more than double in Q2
14 Dec 2021 - Pharmaceutical company Novartis has terminated its agreement with medicine developer Mesoblast (ASX:MSB) prior to closing.